Levacetylmethadol or levomethadyl acetate
- Level
- Commodity
- Parent
- 51371900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51371906This classification denotes an opioid receptor agonist with the molecular formula C23H31NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R3B637Y991, chemically known as 3-heptanol, 6-(dimethylamino)-4,4-diphenyl-, acetate (ester), (3s,6s)-(-)- (8ci) but generally known as levacetylmethadol, which bears US NIH Compound Identifier 15130. European Medicines Agency schedules Levacetylmethadol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08451MIG. World Health Organization schedules levacetylmethadol in its Anatomical Therapeutic Chemical (ATC) Classification. LEVACETYLMETHADOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Levacetylmethadol or levomethadyl acetate bears US NLM identifiers UMLS ID CL414208 and NCI Concept Code C87359. SMILES: O(C(C(CC(N(C)C)C)(C1CCCCC1)C1CCCCC1)CC)C(=O)C.
Same parent
Under 51371900 · 10Activities that produce or sell this
KBLI · 8Inherited from family 51370000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.